Male Infertility Market by Test Type and Treatment - Global Industry Analysis & Forecast to 2027
Published On : August 2020 Pages : 150 Category: Pharma & Healthcare Report Code : HC0812567
Male Infertility Market by Test Type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay, Others) Treatment (Assisted Reproductive Technology and Varicocele Surgery, Medication) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Male Infertility Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Male Infertility is the inability to cause pregnancy in a fertile female and it affects approximately 7% of all men due to deficiencies in the semen, and semen quality is used as a surrogate measure of male fecundity.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer Healthcare
- Andrology solutions
- Aytu BioScience, Inc.
- Cadila Healthcare Ltd.
- Halotech DNA SL
- EMD Sereno, Inc.
- SCSA diagnostics, Inc.
- Intas pharmaceuticals Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Male Infertility Market, By Test Type, Estimates and Forecast, 2017-2027 ($Million)
o DNA Fragmentation Technique
o Oxidative Stress Analysis
o Microscopic Examination
o Sperm Agglutination
o Computer Assisted Semen Analysis
o Sperm Penetration Assay
o Others
· Male Infertility Market, By Treatment, Estimates and Forecast, 2017-2027 ($Million)
o Assisted Reproductive Technology
o Varicocele Surgery
o Medication
· Male Infertility Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Bayer Healthcare
o Andrology solutions
o Aytu BioScience, Inc.
o Cadila Healthcare Ltd.
o Halotech DNA SL
o EMD Sereno, Inc.
o SCSA diagnostics, Inc.
o Intas pharmaceuticals Ltd.
· Male Infertility Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Male Infertility Market , By Country
o U.S. Male Infertility Market
o Canada Male Infertility Market
o Mexico Male Infertility Market
o Europe
§ Europe Male Infertility Market , By Country
o Germany Male Infertility Market
o UK Male Infertility Market
o France Male Infertility Market
o Russia Male Infertility Market
o Italy Male Infertility Market
o Rest of Europe Male Infertility Market
o Asia-Pacific
§ Asia-Pacific Male Infertility Market , By Country
o China Male Infertility Market
o Japan Male Infertility Market
o South Korea Male Infertility Market
o India Male Infertility Market
o Southeast Asia Male Infertility Market
o Rest of Asia-Pacific Male Infertility Market
o South America
§ South America Male Infertility Market , By Country
o Brazil Male Infertility Market
o Argentina Male Infertility Market
o Columbia Male Infertility Market
o Rest of South America Male Infertility Market
o Middle East and Africa
§ Middle East and Africa Male Infertility Market , By Country
o Saudi Arabia Male Infertility Market
o UAE Male Infertility Market
o Egypt Male Infertility Market
o Nigeria Male Infertility Market
o South Africa Male Infertility Market
o Rest of MEA Male Infertility Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Male Infertility Market, By Test Type
5.1. Introduction
5.2. Global Male Infertility Revenue and Market Share by Test Type (2017-2021)
5.2.1. Global Male Infertility Revenue and Revenue Share by Test Type (2017-2021)
5.3. DNA Fragmentation Technique
5.3.1. Global DNA Fragmentation Technique Revenue and Growth Rate (2017-2021)
5.4. Oxidative Stress Analysis
5.4.1. Global Oxidative Stress Analysis Revenue and Growth Rate (2017-2021)
5.5. Microscopic Examination
5.5.1. Global Microscopic Examination Revenue and Growth Rate (2017-2021)
5.6. Sperm Agglutination
5.6.1. Global Sperm Agglutination Revenue and Growth Rate (2017-2021)
5.7. Computer Assisted Semen Analysis
5.7.1. Global Computer Assisted Semen Analysis Revenue and Growth Rate (2017-2021)
5.8. Sperm Penetration Assay
5.8.1. Global Sperm Penetration Assay Revenue and Growth Rate (2017-2021)
5.9. Others
5.9.1. Global Others Revenue and Growth Rate (2017-2021)
6. Male Infertility Market, By Treatment
6.1. Introduction
6.2. Global Male Infertility Revenue and Market Share by Treatment (2017-2021)
6.2.1. Global Male Infertility Revenue and Revenue Share by Treatment (2017-2021)
6.3. Assisted Reproductive Technology
6.3.1. Global Assisted Reproductive Technology Revenue and Growth Rate (2017-2021)
6.4. Varicocele Surgery
6.4.1. Global Varicocele Surgery Revenue and Growth Rate (2017-2021)
6.5. Medication
6.5.1. Global Medication Revenue and Growth Rate (2017-2021)
7. Male Infertility Market, By Region
7.1. Introduction
7.2. Global Male Infertility Revenue and Market Share by Regions
7.2.1. Global Male Infertility Revenue by Regions (2017-2021)
7.3. North America Male Infertility by Countries
7.3.1. North America Male Infertility Revenue and Growth Rate (2017-2021)
7.3.2. North America Male Infertility Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Male Infertility by Countries
7.4.1. Europe Male Infertility Revenue and Growth Rate (2017-2021)
7.4.2. Europe Male Infertility Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Male Infertility by Countries
7.5.1. Asia-Pacific Male Infertility Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Male Infertility Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Male Infertility by Countries
7.6.1. South America Male Infertility Revenue and Growth Rate (2017-2021)
7.6.2. South America Male Infertility Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Male Infertility by Countries
7.7.1. Middle East and Africa Male Infertility Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Male Infertility Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Male Infertility Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Bayer Healthcare
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Andrology solutions
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Aytu BioScience, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Cadila Healthcare Ltd.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Halotech DNA SL
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. EMD Sereno, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. SCSA diagnostics, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Intas pharmaceuticals Ltd.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Male Infertility Market Forecast (2022-2027)
9.1. Global Male Infertility Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Male Infertility Market Forecast by Regions (2022-2027)
9.2.1. North America Male Infertility Market Forecast (2022-2027)
9.2.1.1. United States Male Infertility Market Forecast (2022-2027)
9.2.1.2. Canada Male Infertility Market Forecast (2022-2027)
9.2.1.3. Mexico Male Infertility Market Forecast (2022-2027)
9.2.2. Europe Male Infertility Market Forecast (2022-2027)
9.2.2.1. Germany Male Infertility Market Forecast (2022-2027)
9.2.2.2. France Male Infertility Market Forecast (2022-2027)
9.2.2.3. UK Male Infertility Market Forecast (2022-2027)
9.2.2.4. Russia Male Infertility Market Forecast (2022-2027)
9.2.2.5. Italy Male Infertility Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Male Infertility Market Forecast (2022-2027)
9.2.3. Asia-Pacific Male Infertility Market Forecast (2022-2027)
9.2.3.1. China Male Infertility Market Forecast (2022-2027)
9.2.3.2. Japan Male Infertility Market Forecast (2022-2027)
9.2.3.3. Korea Male Infertility Market Forecast (2022-2027)
9.2.3.4. India Male Infertility Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Male Infertility Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Male Infertility Market Forecast (2022-2027)
9.2.4. South America Male Infertility Market Forecast (2022-2027)
9.2.4.1. Brazil Male Infertility Market Forecast (2022-2027)
9.2.4.2. Argentina Male Infertility Market Forecast (2022-2027)
9.2.4.3. Columbia Male Infertility Market Forecast (2022-2027)
9.2.4.4. Rest of South America Male Infertility Market Forecast (2022-2027)
9.2.5. Middle East and Africa Male Infertility Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Male Infertility Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Male Infertility Market Forecast (2022-2027)
9.2.5.3. Egypt Male Infertility Market Forecast (2022-2027)
9.2.5.4. Nigeria Male Infertility Market Forecast (2022-2027)
9.2.5.5. South Africa Male Infertility Market Forecast (2022-2027)
9.2.5.6. Turkey Male Infertility Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Male Infertility Market Forecast (2022-2027)
9.3. Male Infertility Market Forecast by Test Type (2022-2027)
9.3.1. Male Infertility Forecast by Test Type (2022-2027)
9.3.2. Male Infertility Market Share Forecast by Test Type (2022-2027)
9.4. Male Infertility Market Forecast by Treatment (2022-2027)
9.4.1. Male Infertility Forecast by Treatment (2022-2027)
9.4.2. Male Infertility Market Share Forecast by Treatment (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Male Infertility Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Male Infertility Revenue and Revenue Share by Test Type (2017-2019)
Figure Global DNA Fragmentation Technique Revenue and Growth Rate (2017-2019)
Figure Global Oxidative Stress Analysis Revenue and Growth Rate (2017-2019)
Figure Global Microscopic Examination Revenue and Growth Rate (2017-2019)
Figure Global Sperm Agglutination Revenue and Growth Rate (2017-2019)
Figure Global Computer Assisted Semen Analysis Revenue and Growth Rate (2017-2019)
Figure Global Sperm Penetration Assay Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Male Infertility Revenue and Revenue Share by Treatment (2017-2019)
Figure Global Assisted Reproductive Technology Revenue and Growth Rate (2017-2019)
Figure Global Varicocele Surgery Revenue and Growth Rate (2017-2019)
Figure Global Medication Revenue and Growth Rate (2017-2019)
Table Global Male Infertility Revenue by Regions (2017-2019)
Figure North America Male Infertility Growth Rate (2017-2019)
Figure North America Male Infertility Revenue and Growth Rate (2017-2019)
Figure North America Male Infertility by Countries (2017-2019)
Figure North America Male Infertility Revenue (Million USD) by Countries (2017-2019)
Figure United States Male Infertility Growth Rate (2017-2019)
Figure United States Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Male Infertility Growth Rate (2017-2019)
Figure Canada Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Male Infertility Growth Rate (2017-2019)
Figure Mexico Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Male Infertility Growth Rate (2017-2019)
Figure Europe Male Infertility Revenue and Growth Rate (2017-2019)
Figure Europe Male Infertility by Countries (2017-2019)
Figure Europe Male Infertility Revenue (Million USD) by Countries (2017-2019)
Figure Germany Male Infertility Growth Rate (2017-2019)
Figure Germany Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Male Infertility Growth Rate (2017-2019)
Figure France Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Male Infertility Growth Rate (2017-2019)
Figure UK Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Male Infertility Growth Rate (2017-2019)
Figure Russia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Male Infertility Growth Rate (2017-2019)
Figure Italy Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Male Infertility Growth Rate (2017-2019)
Figure Rest of Europe Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Male Infertility Growth Rate (2017-2019)
Figure Asia-Pacific Male Infertility Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Male Infertility by Countries (2017-2019)
Figure Asia-Pacific Male Infertility Revenue (Million USD) by Countries (2017-2019)
Figure China Male Infertility Growth Rate (2017-2019)
Figure China Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Male Infertility Growth Rate (2017-2019)
Figure Japan Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Male Infertility Growth Rate (2017-2019)
Figure Korea Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Male Infertility Growth Rate (2017-2019)
Figure India Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Male Infertility Growth Rate (2017-2019)
Figure Southeast Asia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Male Infertility Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Male Infertility Growth Rate (2017-2019)
Figure South America Male Infertility Revenue and Growth Rate (2017-2019)
Figure South America Male Infertility by Countries (2017-2019)
Figure South America Male Infertility Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Male Infertility Growth Rate (2017-2019)
Figure Brazil Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Male Infertility Growth Rate (2017-2019)
Figure Argentina Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Male Infertility Growth Rate (2017-2019)
Figure Columbia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Male Infertility Growth Rate (2017-2019)
Figure Rest of South America Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Male Infertility Growth Rate (2017-2019)
Figure Middle East and Africa Male Infertility Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Male Infertility by Countries (2017-2019)
Figure Middle East and Africa Male Infertility Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Male Infertility Growth Rate (2017-2019)
Figure Saudi Arabia Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Male Infertility Growth Rate (2017-2019)
Figure United Arab Emirates Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Male Infertility Growth Rate (2017-2019)
Figure Egypt Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Male Infertility Growth Rate (2017-2019)
Figure Nigeria Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Male Infertility Growth Rate (2017-2019)
Figure South Africa Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Male Infertility Growth Rate (2017-2019)
Figure Turkey Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Male Infertility Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Male Infertility Revenue (Millions USD) and Growth Rate (2017-2019)
Table Bayer Healthcare Male Infertility Financial Overview
Table Andrology solutions Male Infertility Financial Overview
Table Aytu BioScience, Inc. Male Infertility Financial Overview
Table Cadila Healthcare Ltd. Male Infertility Financial Overview
Table Halotech DNA SL Male Infertility Financial Overview
Table EMD Sereno, Inc. Male Infertility Financial Overview
Table SCSA diagnostics, Inc. Male Infertility Financial Overview
Table Intas pharmaceuticals Ltd. Male Infertility Financial Overview
Figure Global Male Infertility Revenue (Millions USD) and Growth Rate (2019-2027)
Table Male Infertility Market Forecast by Regions (2019-2027)
Figure North America Male Infertility Market Forecast (2019-2027)
Figure United States Male Infertility Market Forecast (2019-2027)
Figure Canada Male Infertility Market Forecast (2019-2027)
Figure Mexico Male Infertility Market Forecast (2019-2027)
Figure Europe Male Infertility Market Forecast (2019-2027)
Figure Germany Male Infertility Market Forecast (2019-2027)
Figure France Male Infertility Market Forecast (2019-2027)
Figure UK Male Infertility Market Forecast (2019-2027)
Figure Russia Male Infertility Market Forecast (2019-2027)
Figure Italy Male Infertility Market Forecast (2019-2027)
Figure Rest of Europe Male Infertility Market Forecast (2019-2027)
Figure Asia-Pacific Male Infertility Market Forecast (2019-2027)
Figure China Male Infertility Market Forecast (2019-2027)
Figure Japan Male Infertility Market Forecast (2019-2027)
Figure Korea Male Infertility Market Forecast (2019-2027)
Figure India Male Infertility Market Forecast (2019-2027)
Figure Southeast Asia Male Infertility Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Male Infertility Market Forecast (2019-2027)
Figure South America Male Infertility Market Forecast (2019-2027)
Figure Brazil Male Infertility Market Forecast (2019-2027)
Figure Argentina Male Infertility Market Forecast (2019-2027)
Figure Columbia Male Infertility Market Forecast (2019-2027)
Figure Rest of South America Male Infertility Market Forecast (2019-2027)
Figure Middle East and Africa Male Infertility Market Forecast (2019-2027)
Figure Saudi Arabia Male Infertility Market Forecast (2019-2027)
Figure United Arab Emirates Male Infertility Market Forecast (2019-2027)
Figure Egypt Male Infertility Market Forecast (2019-2027)
Figure Nigeria Male Infertility Market Forecast (2019-2027)
Figure South Africa Male Infertility Market Forecast (2019-2027)
Figure Turkey Male Infertility Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Male Infertility Market Forecast (2019-2027)
Figure Global Male Infertility Forecast by Test Type (2019-2027)
Figure Global Male Infertility Market Share Forecast by Test Type (2019-2027)
Figure Global Male Infertility Forecast by Test Type (2019-2027)
Figure Global Male Infertility Forecast by Treatment (2019-2027)
Figure Global Male Infertility Market Share Forecast by Treatment (2019-2027)
Figure Global Male Infertility Forecast by Treatment (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|